3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
6
Lymphoid
2
Other hematologic neoplasm
1
Gastrointestinal
1
Conditions
Motor Activity
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Hematologic Neoplasms
11
Leukemia
9
Neoplasms
5
Leukemia, Myeloid, Acute
5
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Fatigue
4
Obesity
2
Multiple Myeloma
2
Waldenstrom Macroglobulinemia
1
Stomach Neoplasms
1
Sedentary Behavior
1
Sarcopenia
1
Pulmonary Disease, Chronic Obstructive
1
Parasomnias
1
Pain
1
Overweight
1
Non-alcoholic Fatty Liver Disease
1
Neurotoxicity Syndromes
1
Neuritis
1
Neoplasms, Plasma Cell
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Inflammation
1
Hodgkin Disease
1
Hematologic Diseases
1
Interventions
Doxorubicin
2
hydrocortisone hemisuccinate
1
Vincristine
1
Razoxane
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Mercaptopurine
1
Medical History Taking
1
Leucovorin
1
Laser-Doppler Flowmetry
1
Hydrocortisone
1
Exercise
1
Electrocardiography
1
Echocardiography, Stress
1
Dexrazoxane
1
Cytarabine
1
Blood Cell Count
1
Asparaginase
1
Anthropometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Exercise
×
Other hematologic neoplasm
×
Clear all
NCT02796365
2018-12-13
HF-PROACTIVE
Henry Ford Health System
Phase NA
Completed
29 enrolled